The global research neglect of unassisted smoking cessation: causes and consequences.

PubWeight™: 2.75‹?› | Rank: Top 1%

🔗 View Article (PMC 2817714)

Published in PLoS Med on February 09, 2010

Authors

Simon Chapman1, Ross MacKenzie

Author Affiliations

1: School of Public Health, University of Sydney, Australia. simon.chapman@sydney.edu.au

Articles citing this

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ (2011) 6.19

Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev (2013) 2.33

A novel evaluation of World No Tobacco day in Latin America. J Med Internet Res (2012) 1.73

Suicidal behavior and depression in smoking cessation treatments. PLoS One (2011) 1.65

Smoking behaviour, involuntary smoking, attitudes towards smoke-free legislations, and tobacco control activities in the European Union. PLoS One (2010) 1.35

Tobacco packaging and mass media campaigns: research needs for Articles 11 and 12 of the WHO Framework Convention on Tobacco Control. Nicotine Tob Res (2012) 1.34

Tobacco control, global health policy and development: towards policy coherence in global governance. Tob Control (2012) 1.20

Quantifying the impact and relevance of scientific research. PLoS One (2011) 1.10

Individualized versus population-based approaches to tobacco control - a false dichotomy. Addiction (2011) 1.09

Potential Conflict of Interest and Bias in the RACGP's Smoking Cessation Guidelines: Are GPs Provided with the Best Advice on Smoking Cessation for their Patients? Public Health Ethics (2015) 1.07

Being more realistic about the public health impact of genomic medicine. PLoS Med (2010) 1.06

Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters. BMC Public Health (2011) 1.04

Promotion of tobacco use cessation for lesbian, gay, bisexual, and transgender people: a systematic review. Am J Prev Med (2014) 1.04

Protecting the world from secondhand tobacco smoke exposure: where do we stand and where do we go from here? Nicotine Tob Res (2012) 0.99

Large-scale unassisted smoking cessation over 50 years: lessons from history for endgame planning in tobacco control. Tob Control (2013) 0.99

Correlates of tobacco quit attempts and cessation in the adult population of India: secondary analysis of the Global Adult Tobacco Survey, 2009-10. BMC Public Health (2013) 0.96

The use of cessation assistance among smokers from China: Findings from the ITC China Survey. BMC Public Health (2011) 0.96

Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol (2014) 0.94

Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes. Nicotine Tob Res (2012) 0.94

Research priorities for Article 14--demand reduction measures concerning tobacco dependence and cessation. Nicotine Tob Res (2012) 0.93

Identifying factors to improve oral cancer screening uptake: a qualitative study. PLoS One (2012) 0.91

Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women. Nicotine Tob Res (2010) 0.90

A new policy on tobacco papers. PLoS Med (2010) 0.89

The prevalence of and factors associated with the use of smoking cessation medication in Korea: trend between 2005-2011. PLoS One (2013) 0.88

Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers. Tob Control (2015) 0.87

Tobacco and the invention of quitting: a history of gender, excess and will-power. Sociol Health Illn (2013) 0.86

Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers. BMJ Open (2015) 0.85

Medicinal nicotine nonuse: smokers' rationales for past behavior and intentions to try medicinal nicotine in a future quit attempt. Nicotine Tob Res (2013) 0.84

Why Don't Smokers Want Help to Quit? A Qualitative Study of Smokers' Attitudes towards Assisted vs. Unassisted Quitting. Int J Environ Res Public Health (2015) 0.83

A quantitative estimate of the clinical significance of treating tobacco dependence. Am J Prev Med (2010) 0.83

Increasing availability and consumption of single cigarettes: trends and implications for smoking cessation from the ITC Mexico Survey. Tob Control (2014) 0.81

Tobacco cessation outcomes in a cohort of patients attending a chest medicine outpatient clinic in Bangalore city, southern India. Indian J Med Res (2014) 0.81

The forgotten smoker: a qualitative study of attitudes towards smoking, quitting, and tobacco control policies among continuing smokers. BMC Public Health (2013) 0.81

A qualitative evidence synthesis of employees' views of workplace smoking reduction or cessation interventions. BMC Public Health (2013) 0.81

Characteristics of smoking cessation in former smokers in a rural area of Japan. Int J Prev Med (2012) 0.80

Can genetic risk information for age-related macular degeneration influence motivation to stop smoking? A pilot study. Eye (Lond) (2011) 0.80

Tobacco cessation in India: a priority health intervention. Indian J Med Res (2014) 0.80

Evaluation of a mass media campaign promoting using help to quit smoking. Am J Prev Med (2014) 0.79

The views and experiences of smokers who quit smoking unassisted. A systematic review of the qualitative evidence. PLoS One (2015) 0.78

Strong tobacco control program requirements and secure funding are not enough: lessons from Florida. Am J Public Health (2012) 0.78

A qualitative study of Chinese Canadian fathers' smoking behaviors: intersecting cultures and masculinities. BMC Public Health (2015) 0.78

"Tobacco dependence treatment makes no sense because"…: rebuttal of commonly-heard arguments against providing tobacco dependence treatment in the hospital setting. BMC Public Health (2014) 0.78

Seeking out 'easy targets'? Tobacco companies, health inequalities and public policy. Tob Control (2013) 0.77

Financial strain and smoking cessation among men and women within a self-guided quit attempt. Addict Behav (2015) 0.76

Enabling access to new WHO essential medicines: the case for nicotine replacement therapies. Global Health (2010) 0.76

Lifestyle Vaccines and Public Health: Exploring Policy Options for a Vaccine to Stop Smoking. Public Health Ethics (2016) 0.75

Research funding for addressing tobacco-related disease: an analysis of UK investment between 2008 and 2012. BMJ Open (2016) 0.75

New insights into smoking cessation question the effectiveness of nicotine replacement therapy. J Clin Epidemiol (2016) 0.75

A Smoke-Free Paso del Norte: impact over 10 years on smoking prevalence using the Behavioral Risk Factor Surveillance System. Am J Public Health (2011) 0.75

Outcome of tobacco cessation in workplace and clinic settings: A comparative study. J Int Soc Prev Community Dent (2016) 0.75

Quit Methods Used by US Adult Cigarette Smokers, 2014-2016. Prev Chronic Dis (2017) 0.75

Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers. BMJ Open (2015) 0.75

Conceptual obstacles to making use of four smoking-cessation strategies: What reasons do light smokers give for rejecting strategies? Health Psychol Open (2015) 0.75

Smoking cessation and long-term weight gain in the Framingham Heart Study: an application of the parametric g-formula for a continuous outcome. Eur J Epidemiol (2016) 0.75

Measured, opportunistic, unexpected and naïve quitting: a qualitative grounded theory study of the process of quitting from the ex-smokers' perspective. BMC Public Health (2017) 0.75

Articles cited by this

Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ (2002) 14.51

Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev (2008) 8.69

Criteria for evaluating evidence on public health interventions. J Epidemiol Community Health (2002) 8.16

Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA (2002) 5.63

Methods used to quit smoking in the United States. Do cessation programs help? JAMA (1990) 5.57

How reactions to cigarette packet health warnings influence quitting: findings from the ITC Four-Country survey. Addiction (2009) 5.37

Use of smoking-cessation treatments in the United States. Am J Prev Med (2008) 4.35

Hardening and the hard-core smoker: concepts, evidence, and implications. Nicotine Tob Res (2003) 4.21

"Catastrophic" pathways to smoking cessation: findings from national survey. BMJ (2006) 3.95

Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med (2000) 3.92

Impact of tobacco control policies and mass media campaigns on monthly adult smoking prevalence. Am J Public Health (2008) 3.72

To what extent do smokers plan quit attempts? Tob Control (2005) 3.71

The effects of the anti-smoking campaign on cigarette consumption. Am J Public Health (1977) 3.68

Tobacco addiction. Lancet (2008) 3.65

Attempts to quit smoking and relapse: factors associated with success or failure from the ATTEMPT cohort study. Addict Behav (2008) 3.52

Uptake and effectiveness of the Australian telephone Quitline service in the context of a mass media campaign. Tob Control (2003) 2.78

A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control (2003) 2.67

Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys. Am J Psychiatry (2006) 2.62

The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci (2004) 2.53

Factors associated with successful smoking cessation in the United States, 2000. Am J Public Health (2007) 2.49

The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res (2004) 2.28

Unravelling gossamer with boxing gloves: problems in explaining the decline in smoking. BMJ (1993) 2.23

Recovery from alcohol problems with and without treatment: prevalence in two population surveys. Am J Public Health (1996) 2.11

Recidivism and self-cure of smoking and obesity. Am Psychol (1982) 2.02

Use of tobacco cessation treatments among young adult smokers: 2005 National Health Interview Survey. Am J Public Health (2007) 2.01

Economics of smoking cessation. BMJ (2004) 1.97

The impact of pharmaceutical company funding on results of randomized trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction (2007) 1.92

A national strategy for smoking cessation treatment in England. Addiction (2005) 1.84

Characteristics of selectors of nicotine replacement therapy. Tob Control (2005) 1.74

Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health (2002) 1.72

Studies on natural recovery from alcohol dependence: sample selection bias by media solicitation? Addiction (2000) 1.65

Impact of nicotine replacement therapy on smoking behavior. Annu Rev Public Health (2005) 1.65

Unplanned quit attempts--results from a U.S. sample of smokers and ex-smokers. Nicotine Tob Res (2009) 1.57

Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003. Addiction (2005) 1.56

Follow the money--the politics of embryonic stem cell research. PLoS Biol (2005) 1.48

Smoking and cessation behaviors among young adults of various educational backgrounds. Am J Public Health (2007) 1.48

In defence of helping people to stop smoking. Lancet (2009) 1.46

Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study. J Clin Pharm Ther (2006) 1.46

The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addict Behav (2004) 1.46

Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness. Drug Alcohol Rev (2008) 1.31

The motivation for change from problem alcohol and heroin use. Br J Addict (1991) 1.26

Natural and treatment-assisted recovery from gambling problems: a comparison of resolved and active gamblers. Addiction (2000) 1.24

Factors associated with untreated remissions from alcohol abuse or dependence. Addict Behav (2000) 1.16

Smoking cessation treatment in a public-health context. Lancet (2008) 1.13

Interest in gradual cessation. Nicotine Tob Res (2007) 1.09

Nicotine addiction through a neurogenomic prism: ethics, public health, and smoking. Nicotine Tob Res (2005) 0.98

Factors associated with outcome in unaided smoking cessation, and a comparison of those who have never tried to stop with those who have. Br J Gen Pract (1994) 0.98

The inverse impact law of smoking cessation. Lancet (2009) 0.94

Smoking status of Australian general practice patients and their attempts to quit. Addict Behav (2005) 0.89

Quit smoking behaviours and intentions and hard-core smoking in New South Wales. Health Promot J Austr (2006) 0.88

NHS smoking cessation services and smoking prevalence: observational study. BMJ (2005) 0.85

The role of natural recovery in alcoholism and pathological gambling. J Gambl Stud (2003) 0.83

Dependent behaviours and beliefs: a qualitative study of older long-term smokers with arterial disease. Addiction (2001) 0.83

On the structural constraints to state intervention in health. Int J Health Serv (1975) 0.79

Articles by these authors

Dr. Richard Singer: a master number cruncher. J Insur Med (2010) 1.93

The cancer emperor's new clothes: Australia's historic legislation for plain tobacco packaging. BMJ (2010) 1.12

Anemia and mortality in older persons: does the type of anemia affect survival? Int J Hematol (2012) 0.87

The World Cup, sport sponsorship, and health. Lancet (2006) 0.85

There's nothing that succeeds like failure: discerning the woods from the trees in smoking cessation debates. Nicotine Tob Res (2012) 0.81

From brand to bland--the demise of cigarette packaging. BMJ (2011) 0.77

Life expectancy for people with disabilities. NeuroRehabilitation (2011) 0.75

NT-proBNP and life insurance revisited. J Insur Med (2014) 0.75

Whither mortality abstracts? J Insur Med (2011) 0.75

Smoking--still a mortality issue for life insurers. J Insur Med (2008) 0.75

Natriuretic peptide testing--ready for insurance screening? J Insur Med (2007) 0.75

New laboratory tests and the medical director. J Insur Med (2007) 0.75

Recollections of the carcinoembryonic antigen as played on a blue guitar. J Insur Med (2007) 0.75

Infarction or Pseudo-infarction? J Insur Med (2017) 0.75

Goldberger's triad. J Insur Med (2014) 0.75

Negative T Waves Again. J Insur Med (2015) 0.75

A Perplexing ECG. J Insur Med (2016) 0.75

GI Joe and international medicine. J Insur Med (2009) 0.75

Transitioning from a Paper-based to an Electronic Version of the Journal of Insurance Medicine. J Insur Med (2015) 0.75

Unexpected right axis deviation. J Insur Med (2014) 0.75

A "Full Monty" Issue of the Journal. J Insur Med (2017) 0.75

All-Cause Mortality for Diabetics or Individuals with Hyperglycemia Applying for Life Insurance. J Insur Med (2016) 0.75

Donald Gleason and the grading of prostate cancer. J Insur Med (2009) 0.75

Unusual QRS Pattern in the Early Precordial Leads. J Insur Med (2015) 0.75

All-Cause Mortality for Life Insurance Applicants with a History of Breast Cancer. J Insur Med (2017) 0.75

Isolated T-wave inversion in the right precordial leads. J Insur Med (2014) 0.75